Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by prophetoffactzon Feb 12, 2024 1:12pm
87 Views
Post# 35875831

RE:The board of AEZS and CZO should be ashamed of themselves

RE:The board of AEZS and CZO should be ashamed of themselves"Proph keeps telling us how enthusiastic gilles and Ronnie are. Unlike us, they are not taking any risks, on the contrary, they are being paid handsomely for all this."

The merged company will effectively have a C$36 million market cap at C$.23 per CZO share with C$62.24 million cash as of last report. At ~C$.40 per CZO share the merged company would be trading at the level of cash of the two companies as of the last report. CZO's near-term revenue generating opportunities would be fully financed. CZO shareholders also pick up AEZS's diagnostic test and diversification with the pipeline. AEZS also has significant tax loss carryforwards.


<< Previous
Bullboard Posts
Next >>